Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN

Clinical trial NCT03878979 · COMPLETED

Trial details

NCT number: NCT03878979
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Head and Neck Cancer Head and Neck Cancer Metastatic

Start date: 2019-07-08
Primary completion: 2023-10-17
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.